biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Jan 11, 2018 4:39pm

109 Views

Post# 27336770

RE:RE:RE:RE:Quite Weary Sum

Well, I’ve been pouting for a long time but ironically adding shares thinking I was ahead of the game.
kayacker, I hear you when you mention suspecting that people were awaiting a NR at same time paired as the conference which I wasn’t. These conferences dont do squat for me but anyways, conferences are part of the play if you want to get known or mentioned.
But suspecting is an opinion and an opinion is always debatable but .70 cents on no volume is a fact and as far as I know, no one has yet been able to debate a fact.

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains